SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Xylo Technologies Ltd. MDGS NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • IL • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Xylo Technologies Ltd. (MDGS) is a Medical - Devices company in the Healthcare sector, currently trading at $2.36. It has a SharesGrow Score of 31/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $92M, +871.1%/yr average growth. Net income is $16M (loss), growing at -83.4%/yr. Net profit margin is -17.5% (negative). Gross margin is 12.9% (+107.6 pp trend).

Balance sheet: total debt is $10M against $24M equity (Debt-to-Equity (D/E) ratio 0.42, conservative). Current ratio is 1.08 (adequate). Debt-to-assets is 15.3%. Total assets: $64M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 25/100 (Fail), Health 50/100 (Partial), Moat 22/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

MDGS SharesGrow Score Overview

33/100

SharesGrow Score

Below average — proceed with caution

View full scorecard →

VALUE 0/100

Valuation — P/E, PEG, Forward PEG

GROWTH 58/100

Financials — average growth

PAST 25/100

strong — trend

HEALTH 50/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 22/100

Gross margin is + market cap

FUTURE 0/100

Analyst outlook — as buy

INCOME 10/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — MDGS

No analyst coverage available for this stock.

MDGS: +871.1%/yr revenue is, -83.4%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

MDGS: 1 / 4 years profitable. weak. Score = 1 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet MDGS: Debt-to-Equity (D/E) ratio 0.42 (conservative), Current ratio is 1.08 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

MDGS: Gross margin is 12.9% (+107.6 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 22/100. ≥ 70 = Pass.

View details →

No analyst coverage available for this stock.

MDGS: Net profit margin is -17.5%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range1.5396-7.17

Volume25.63K

Avg Volume (30D)13.22K

Market Cap$178.86M

Beta (1Y)1.37

Dividend Yield$0.8500

Share Statistics

EPS (TTM)-9.50

Shares Outstanding$1.69M

IPO Date2015-08-05

Employees38

CEOLiron Carmel

Financial Highlights & Ratios

Revenue (TTM)$91.72M

Gross Profit$11.84M

EBITDA$-12.84M

Net Income$-16.03M

Operating Income$-23.32M

Total Cash$12.54M

Total Debt$9.79M

Net Debt$429K

Total Assets$63.9M

Price / Earnings (P/E)-0.2

Price / Sales (P/S)1.95

Analyst Forecast

Company Info

CountryIL

ExchangeNASDAQ Capital Marke

CurrencyUSD

ISINUS58471G4091

Price Chart

MDGS

Xylo Technologies Ltd. ↗ · NASDAQ Capital Marke

Healthcare • Medical - Devices

1.54 52WK RANGE 7.17

People Also View

Heska Corporation

Paragon 28, Inc.

Surmodics, Inc.

Delcath Systems, Inc.

Nortech Systems Incorporated

IceCure Medical Ltd

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message